Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Erectile Dysfunction
Interventions
DRUG

Vardenafil ODT (STAXYN, BAY38-9456)

Subjects will receive 12 weeks of PRN (on demand) treatment with Vardenafil 10mg orodispersible tablet (ODT)

DRUG

Placebo

Subjects will receive 12 weeks of PRN (on demand) treatment with matching placebo tablet

Trial Locations (47)

1000

Bruxelles - Brussel

1070

Bruxelles - Brussel

1200

Bruxelles - Brussel

1739

Krugersdorp

1818

Johannesburg

2020

Antwerp

2198

Johannesburg

3600

Genk

4000

Liège

4001

Durban

4037

Durban

4091

Durban

7463

Cape Town

7530

Cape Town

9000

Ghent

13006

Marseille

13009

Marseille

20246

Hamburg

20354

Hamburg

36211

Vigo

38320

San Cristóbal de La Laguna

40000

Mont-de-Marsan

41063

Mönchengladbach

45468

Mülheim

46010

Valencia

49076

Osnabrück

59000

Lille

69000

Lyon

69437

Lyon

75008

Paris

81925

München

92637

Weiden

02625

Bautzen

04109

Leipzig

01662

Meissen

6836 BH

Arnhem

5751 XJ

Deurne

2316 ZL

Leiden

7581 BV

Losser

6212 XN

Maastricht

7442 LS

Nijverdal

0140

Centurion

0001

Pretoria

0083

Pretoria

03010

Alicante

08003

Barcelona

08034

Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Schering-Plough

INDUSTRY

lead

Bayer

INDUSTRY